Local activation of cannabinoid CB<sub>1 </sub>receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
<p>Abstract</p> <p>Background</p> <p>Systemic administration of cannabinoid agonists is known to reduce pain induced by bladder inflammation and to modulate cystometric parameters <it>in vivo</it>. We have previously reported that intravesical administration...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-05-01
|
| Series: | Molecular Pain |
| Online Access: | http://www.molecularpain.com/content/7/1/31 |